Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan · Delayed Price · Currency is TWD 82.70
-0.70 (-0.84%)
Sep 4, 2025, 2:31 PM CST
Foresee Pharmaceuticals Market Cap
Foresee Pharmaceuticals has a market cap or net worth of 12.81 billion as of September 4, 2025. Its market cap has increased by 21.57% in one year.
Market Cap
12.81B
Enterprise Value
12.19B
Revenue
442.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
82.70
Market Cap Chart
Since April 12, 2016, Foresee Pharmaceuticals's market cap has increased from 7.35B to 12.81B, an increase of 74.21%. That is a compound annual growth rate of 6.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 12.81B | 6.76% |
| Dec 31, 2024 | 12.00B | -8.16% |
| Dec 29, 2023 | 13.06B | 20.98% |
| Dec 30, 2022 | 10.80B | -23.14% |
| Dec 30, 2021 | 14.05B | 34.12% |
| Dec 31, 2020 | 10.47B | 79.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Apr 12, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 359.06B |
| PharmaEssentia | 170.30B |
| Bora Pharmaceuticals Co., LTD. | 90.35B |
| Lotus Pharmaceutical | 50.76B |
| Lumosa Therapeutics | 37.82B |
| Oneness Biotech | 37.54B |
| Polaris Group | 29.16B |
| Center Laboratories | 28.56B |